BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 16152798)

  • 21. Apolipoprotein E polymorphism in northwestern Greece: frequency and effect on lipid parameters.
    Liberopoulos E; Miltiadous G; Hatzivassiliou M; Ayrton N; Bairaktari E; Cariolou M; Elisaf M
    Ann Clin Lab Sci; 2004; 34(3):347-54. PubMed ID: 15487712
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The TGF-beta 1 gene codon 10 polymorphism contributes to the genetic predisposition to nephropathy in Type 1 diabetes.
    Patel A; Scott WR; Lympany PA; Rippin JD; Gill GV; Barnett AH; Bain SC;
    Diabet Med; 2005 Jan; 22(1):69-73. PubMed ID: 15606694
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association between apolipoprotein E genetic polymorphism and the development of diabetic nephropathy in type 2 diabetic patients.
    Kwon MK; Rhee SY; Chon S; Oh S; Woo JT; Kim SW; Kim JW; Kim YS; Jeong KH; Lee SH; Lee TW; Ihm CG
    Diabetes Res Clin Pract; 2007 Sep; 77 Suppl 1():S228-32. PubMed ID: 17624465
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Polymorphic markers of the NO synthase genes and genetic predisposition to diabetic polyneuropathy in patients with type 1 diabetes mellitus].
    Zotova EV; Voron'ko OE; Bursa TR; Galeev IV; Strokov IA; Nosikov VV
    Mol Biol (Mosk); 2005; 39(2):224-9. PubMed ID: 15856945
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Apolipoprotein E genotype affects the response to lipid-lowering therapy in Chinese patients with type 2 diabetes mellitus.
    Tavintharan S; Lim SC; Chan YH; Sum CF
    Diabetes Obes Metab; 2007 Jan; 9(1):81-6. PubMed ID: 17199722
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ε2 allele and ε2-involved genotypes (ε2/ε2, ε2/ε3, and ε2/ε4) may confer the association of APOE genetic polymorphism with risks of nephropathy in type 2 diabetes: a meta-analysis.
    Shi J; Cheng Z; Qiu S; Cui H; Gu Y; Zhao Q; Ren Y; Zhang H; Sun H; Liu Y; Li Y; Qiao Y; Hu Y; Liu Y; Cheng Y
    Lipids Health Dis; 2020 Jun; 19(1):136. PubMed ID: 32534589
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Apolipoprotein E genetic polymorphism, remnant lipoproteins, and nephropathy in type 2 diabetic patients.
    Eto M; Saito M; Okada M; Kume Y; Kawasaki F; Matsuda M; Yoneda M; Matsuki M; Takigami S; Kaku K
    Am J Kidney Dis; 2002 Aug; 40(2):243-51. PubMed ID: 12148096
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Search for the association of polymorphic markers for genes coding for antioxidant defense enzymes, with development of diabetic polyneuropathies in patients with type 1 diabetes mellitus].
    Zotova EV; Savost'ianov KV; Chistiakov DA; Bursa TR; Galeev IV; Strokov IA; Nosikov VV
    Mol Biol (Mosk); 2004; 38(2):244-9. PubMed ID: 15125229
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Influence of the APOE genotypes in some atherosclerotic risk factors].
    Carmo Martins M; Lima Faleiro L; Rodrigues MO; Albergaria I; Fonseca A
    Acta Med Port; 2008; 21(5):433-40. PubMed ID: 19187685
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of apolipoprotein E gene polymorphism on development of type 2 diabetes mellitus in Chinese Han population: a meta-analysis of 29 studies.
    Yin YW; Qiao L; Sun QQ; Hu AM; Liu HL; Wang Q; Hou ZZ
    Metabolism; 2014 Apr; 63(4):532-41. PubMed ID: 24439487
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association between apolipoprotein E polymorphism and nephropathy in Iranian diabetic patients.
    Karimoei M; Pasalar P; Mehrabzadeh M; Daneshpour M; Shojaee M; Forouzanfar K; Razi F
    Saudi J Kidney Dis Transpl; 2017; 28(5):997-1002. PubMed ID: 28937055
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Associations between Ser447Ter gene polymorphism of lipoprotein lipase and atherosclerotic cerebral infarction].
    Guan GD; Xu E; Wang XJ; Xu YH; Qiu SD
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Oct; 23(5):519-22. PubMed ID: 17029199
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Associations between apolipoprotein E gene polymorphism and plasminogen activator inhibitor-1 and atherogenic lipid profile in dialysis patients.
    Arikan H; Koc M; Sari H; Tuglular S; Ozener C; Akoglu E
    Ren Fail; 2007; 29(6):713-9. PubMed ID: 17763167
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polymorphism of the aldosterone synthase gene is not associated with progression of diabetic nephropathy, but associated with hypertension in type 2 diabetic patients.
    Ko GJ; Kang YS; Lee MH; Song HK; Kim HK; Cha DR
    Nephrology (Carlton); 2008 Dec; 13(6):492-9. PubMed ID: 18771471
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The xylosyltransferase I gene polymorphism c.343G>T (p.A125S) is a risk factor for diabetic nephropathy in type 1 diabetes.
    Schön S; Prante C; Bahr C; Tarnow L; Kuhn J; Kleesiek K; Götting C
    Diabetes Care; 2006 Oct; 29(10):2295-9. PubMed ID: 17003309
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Apolipoprotein E polymorphism in Turkish subjects with Type 2 diabetes mellitus: allele frequency and relation to serum lipid concentrations.
    Duman BS; Oztürk M; Yilmazer S; Hatemi H
    Diabetes Nutr Metab; 2004 Oct; 17(5):267-74. PubMed ID: 16295048
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Apolipoprotein E gene polymorphisms in Lebanese with hypercholesterolemia.
    Mahfouz RA; Charafeddine KM; Tanios RF; Karaky NM; Abdul Khalik RN; Daher RT
    Gene; 2013 Jun; 522(1):84-8. PubMed ID: 23537987
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of the apolipoprotein E gene, its promoter polymorphisms and haplotypes with depressive symptoms. The Cardiovascular Risk in Young Finns Study.
    Elovainio M; Puttonen S; Pulkki-Råback L; Kivimaki M; Viiri LE; Lehtimaki T; Karhunen P; Viikari J; Raitakari OT; Keltikangas-Jarvinen L
    Neuropsychobiology; 2008; 58(2):91-6. PubMed ID: 18843194
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gender-related effect of apo E polymorphism on lipoprotein particle sizes in the middle-aged subjects.
    Topic A; Spasojevic Kalimanovska V; Zeljkovic A; Vekic J; Jelic Ivanovic Z
    Clin Biochem; 2008 Apr; 41(6):361-7. PubMed ID: 18086568
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Identification of the locus associated with diabetic nephropathy in type 1 diabetes mellitus].
    Savost'ianov KV; Chistiakov DA; Shestakova MV; Voron'ko OE; Chugunova LA; Shamkhalova MSh; Dedov II; Nosikov VV
    Mol Biol (Mosk); 2002; 36(6):1015-20. PubMed ID: 12500539
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.